Francesca Fallarino

Dr. Francesca Fallarino

University of Perugia
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Immunity
Verified
Journal Article
Closed access
TERESA ZELANTETERESA ZELANTE
TERESA ZELANTE
RIRossana G. Iannitti
Rossana G. Iannitti
CCCristina Cunha
Cristina Cunha
ALAntonella De Luca
Antonella De Luca
GGGloria Giovannini
Gloria Giovannini
LRLuigina Romani
Luigina Romani

13 February 2019 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
MPMichael Platten
Michael Platten
ENEllen A. A. Nollen
Ellen A. A. Nollen
URUte Röhrig
Ute Röhrig
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
COChristiane A. Opitz
Christiane A. Opitz

26 October 2003 in Nature Immunology
Verified
Journal Article
Closed access
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
KHKwang Woo Hwang
Kwang Woo Hwang
COCiriana Orabona
Ciriana Orabona
CVCarmine Vacca
Carmine Vacca
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

30 September 2002 in Nature Immunology
Verified
Journal Article
Closed access
UGUrsula Grohmann
Ursula Grohmann
COCiriana Orabona
Ciriana Orabona
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
CVCarmine Vacca
Carmine Vacca
FCFilippo Calcinaro
Filippo Calcinaro
Paolo PuccettiPaolo Puccetti
Paolo Puccetti

1 June 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
SYSylvaine You
Sylvaine You
BMBarbara C. McGrath
Barbara C. McGrath
DCDouglas R. Cavener
Douglas R. Cavener
Paolo PuccettiPaolo Puccetti
Paolo Puccetti
Tryptophan catabolism is a tolerogenic effector system in regulatory T cell function, yet the general mechanisms whereby tryptophan catabolism affects T cell responses remain unclear. We provide evidence that the short-term, combined effects of tryptophan deprivation and tryptophan catabolites result in GCN2 kinase-dependent down-regulation of the TCR ζ-chain in murine CD8+ T cells. TCR ζ down-regulation can be demonstrated in vivo and is associated with an impaired cytotoxic effector function in vitro. The longer-term effects of tryptophan catabolism include the emergence of a regulatory phenotype in naive CD4+CD25− T cells via TGF-β induction of the forkhead transcription factor Foxp3. Such converted cells appear to be CD25+, CD69−, CD45RBlow, CD62L+, CTLA-4+, BTLAlow and GITR+, and are capable of effective control of diabetogenic T cells when transferred in vivo. Thus, both tryptophan starvation and tryptophan catabolites contribute to establishing a regulatory environment affecting CD8+ as well as CD4+ T cell function, and not only is tryptophan catabolism an effector mechanism of tolerance, but it also results in GCN2-dependent generation of autoimmune-preventive regulatory T cells.

1 October 2002 in Cell Death & Differentiation
Verified
Journal Article
Closed access
Francesca FallarinoFrancesca Fallarino
Francesca Fallarino
UGUrsula Grohmann
Ursula Grohmann
CVC Vacca
C Vacca
RBR Bianchi
R Bianchi
COCiriana Orabona
Ciriana Orabona
Paolo PuccettiPaolo Puccetti
Paolo Puccetti